What are the options for hemochromatosis treatment?

Hemochromatosis treatment primarily involves regular phlebotomy (blood removal) to reduce iron levels, along with dietary modifications and iron chelation therapy in some cases. Early diagnosis and consistent treatment can prevent serious complications and allow patients to live normal, healthy lives.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Hemochromatosis and Why Treatment Matters

Hemochromatosis is a genetic disorder that causes your body to absorb too much iron from food, leading to dangerous iron buildup in vital organs like the liver, heart, and pancreas. Without proper treatment, this excess iron can cause serious complications including liver cirrhosis, heart failure, diabetes, and arthritis. The good news is that with early detection and appropriate treatment, people with hemochromatosis can prevent these complications and maintain normal life expectancy.

The key to successful hemochromatosis management lies in reducing iron levels to normal ranges and maintaining them through ongoing treatment. Treatment approaches vary based on the severity of iron overload, the presence of organ damage, and individual patient factors. Understanding your treatment options empowers you to work effectively with your healthcare team to develop a personalized management plan.

Phlebotomy: The Gold Standard Treatment

Therapeutic phlebotomy, essentially blood donation performed for medical purposes, remains the most effective and widely used treatment for hemochromatosis. This simple procedure removes approximately 500 milliliters of blood, which contains about 200-250 milligrams of iron. By regularly removing blood, your body uses stored iron to produce new red blood cells, gradually reducing iron overload.

Comparison of Hemochromatosis Treatment Options

Treatment effectiveness varies by individual. Phlebotomy remains the gold standard for most patients with hemochromatosis.
Treatment MethodEffectivenessFrequencySide Effects
PhlebotomyPhlebotomyHighly effective (>95%)Weekly initially, then every 2-4 monthsMild fatigue, lightheadedness
Iron ChelationIron ChelationModerately effectiveDaily medicationGI upset, skin reactions, potential organ toxicity
Dietary ChangesDietary ChangesSupportive onlyOngoing lifestyle modificationNone when properly balanced

Treatment effectiveness varies by individual. Phlebotomy remains the gold standard for most patients with hemochromatosis.

Initial Treatment Phase

During the initial treatment phase, also called the de-ironing phase, patients typically undergo phlebotomy once or twice weekly. This intensive schedule continues until ferritin levels drop below 50-100 ng/mL and transferrin saturation normalizes below 45%. Depending on the severity of iron overload, this phase can last anywhere from several months to over a year. Most patients tolerate the procedure well, though some may experience temporary fatigue or lightheadedness.

Your healthcare provider will monitor your iron levels closely during this phase through regular blood tests. Key biomarkers include serum ferritin, transferrin saturation, hemoglobin, and hematocrit levels. If you're interested in tracking these important markers regularly, comprehensive testing can provide valuable insights into your treatment progress.

Maintenance Phase

Once iron levels normalize, patients enter the maintenance phase, requiring phlebotomy every 2-4 months to prevent iron re-accumulation. The frequency depends on individual iron absorption rates, dietary habits, and genetic factors. Some patients may need more frequent sessions, while others can maintain normal levels with quarterly treatments. Regular monitoring ensures your treatment schedule remains optimal for your specific needs.

Dietary Management Strategies

While phlebotomy addresses existing iron overload, dietary modifications help minimize ongoing iron absorption. Although diet alone cannot treat hemochromatosis, smart nutritional choices complement medical treatment and may reduce the frequency of phlebotomy sessions needed during maintenance.

Foods and Supplements to Avoid

  • Iron-fortified foods and cereals
  • Vitamin C supplements (enhance iron absorption)
  • Raw shellfish (risk of Vibrio vulnificus infection)
  • Alcohol (accelerates liver damage)
  • Iron supplements and multivitamins containing iron

Beneficial Dietary Choices

  • Tea and coffee with meals (tannins reduce iron absorption)
  • Calcium-rich foods during iron-containing meals
  • Whole grains and fiber-rich foods
  • Lean proteins from poultry and fish
  • Fruits and vegetables (except those high in vitamin C with meals)

Working with a registered dietitian familiar with hemochromatosis can help you develop a balanced eating plan that supports your treatment goals while ensuring adequate nutrition. Remember that dietary changes supplement but don't replace medical treatment.

Iron Chelation Therapy: An Alternative Approach

For patients who cannot undergo phlebotomy due to anemia, poor venous access, or other medical conditions, iron chelation therapy offers an alternative treatment option. Chelating agents are medications that bind to excess iron in the body, allowing it to be eliminated through urine or stool.

Available Chelation Medications

The most commonly prescribed iron chelator for hemochromatosis is deferoxamine (Desferal), administered through subcutaneous or intravenous infusion. Newer oral chelators like deferasirox (Exjade) and deferiprone (Ferriprox) may be options for some patients, though they're primarily approved for transfusion-related iron overload. These medications require careful monitoring for side effects and may be more expensive than phlebotomy.

Chelation therapy typically removes iron more slowly than phlebotomy and may cause side effects including gastrointestinal upset, skin reactions, and potential kidney or liver toxicity. Regular blood tests are essential to monitor treatment effectiveness and detect any adverse effects early.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Managing Complications and Organ Damage

When hemochromatosis is diagnosed late or left untreated, iron accumulation can cause irreversible organ damage. While reducing iron levels prevents further damage, existing complications require specific management strategies alongside iron reduction therapy.

Liver Disease Management

Liver complications, ranging from fibrosis to cirrhosis, affect up to 75% of symptomatic hemochromatosis patients. Treatment includes regular phlebotomy to prevent further damage, avoidance of alcohol and hepatotoxic medications, and monitoring for hepatocellular carcinoma through ultrasounds and alpha-fetoprotein testing. Patients with advanced cirrhosis may require liver transplantation, though this is rare with early treatment.

Cardiac and Endocrine Complications

Iron-induced cardiomyopathy may improve with aggressive iron removal, though some patients require additional cardiac medications. Diabetes from pancreatic iron deposits typically requires standard diabetes management alongside phlebotomy. Hormone replacement therapy may be necessary for hypogonadism, while thyroid dysfunction requires appropriate hormone supplementation.

Monitoring and Long-term Management

Successful hemochromatosis treatment requires lifelong monitoring and management. Regular blood tests track iron levels and screen for complications, while imaging studies assess organ health. Key monitoring parameters include ferritin, transferrin saturation, liver enzymes, glucose levels, and cardiac function markers.

Patients should undergo comprehensive health assessments annually, including liver ultrasounds for those with fibrosis or cirrhosis. Bone density scans help detect osteoporosis, a common complication. Regular monitoring allows for early detection and treatment of complications, significantly improving long-term outcomes. For convenient at-home monitoring of key health markers, consider comprehensive testing programs that track multiple biomarkers relevant to hemochromatosis management.

Special Considerations for Different Patient Groups

Treatment approaches may need modification for certain patient populations. Pregnant women typically postpone phlebotomy until after delivery, as pregnancy naturally increases iron requirements. Children with juvenile hemochromatosis may require more aggressive treatment due to rapid iron accumulation. Elderly patients might need adjusted phlebotomy schedules based on their tolerance and comorbid conditions.

Patients with compound heterozygous mutations or non-HFE hemochromatosis may have different iron accumulation patterns requiring individualized treatment protocols. Those with concurrent conditions like hepatitis C or metabolic syndrome need coordinated care addressing all health issues simultaneously.

Living Well with Hemochromatosis

With proper treatment, most people with hemochromatosis can live normal, healthy lives. Early diagnosis and consistent treatment prevent organ damage and complications. Many patients find that regular phlebotomy becomes a routine part of life, no more burdensome than regular dental cleanings or other preventive health measures.

Support groups and patient organizations provide valuable resources and community connections. Genetic counseling helps family members understand their risk and the importance of screening. By taking an active role in your treatment and maintaining open communication with your healthcare team, you can effectively manage hemochromatosis and maintain excellent quality of life.

Remember that hemochromatosis treatment is highly effective when started early and maintained consistently. Regular monitoring, adherence to treatment schedules, and healthy lifestyle choices form the foundation of successful long-term management. If you're looking to understand your current iron status and overall health markers, consider uploading your existing blood test results to SiPhox Health's free analysis service for personalized insights and recommendations tailored to your unique health profile.

References

  1. Adams PC, Barton JC. How I treat hemochromatosis. Blood. 2010;116(3):317-325.[Link][PubMed][DOI]
  2. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1):328-343.[PubMed][DOI]
  3. European Association for the Study of the Liver. EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol. 2010;53(1):3-22.[PubMed][DOI]
  4. Brissot P, de Bels F. Current approaches to the management of hemochromatosis. Hematology Am Soc Hematol Educ Program. 2006:36-41.[PubMed][DOI]
  5. Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet. 2016;388(10045):706-716.[PubMed][DOI]
  6. Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG Clinical Guideline: Hereditary Hemochromatosis. Am J Gastroenterol. 2019;114(8):1202-1218.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my ferritin and iron levels at home?

You can test your ferritin at home with SiPhox Health's Core Health Program, which includes ferritin testing along with other essential biomarkers. This CLIA-certified program provides lab-quality results from the comfort of your home, helping you monitor your iron status regularly.

How often do I need phlebotomy treatments for hemochromatosis?

Initially, most patients need phlebotomy once or twice weekly until iron levels normalize. After reaching target levels, maintenance phlebotomy is typically needed every 2-4 months, though frequency varies based on individual iron absorption rates and dietary habits.

Can hemochromatosis be cured completely?

Hemochromatosis cannot be cured since it's a genetic condition, but it can be effectively managed with regular treatment. With consistent phlebotomy and monitoring, patients can maintain normal iron levels and prevent complications, living normal, healthy lives.

What foods should I avoid with hemochromatosis?

Avoid iron-fortified foods, vitamin C supplements, raw shellfish, excessive alcohol, and iron supplements. Limit red meat consumption and consider drinking tea or coffee with meals to reduce iron absorption.

Are there any side effects from phlebotomy treatment?

Most patients tolerate phlebotomy well, though some may experience temporary fatigue, lightheadedness, or mild bruising at the needle site. These effects typically resolve quickly, and staying well-hydrated before and after treatment helps minimize discomfort.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details